Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
about
Migration of bone marrow progenitor cells in the adult brain of rats and rabbitsDipeptidyl Peptidase-4 Regulation of SDF-1/CXCR4 Axis: Implications for Cardiovascular DiseaseLysophospholipids and their receptors in the central nervous systemGPCRs in stem cell functionA novel role for bioactive lipids in stem cell mobilization during cardiac ischemia: new paradigms in thrombosis: novel mediators and biomarkersRegulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing.Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protectionFTY720 protects cardiac microvessels of diabetes: a critical role of S1P1/3 in diabetic heart diseaseSphingosine-1-Phosphate Receptor-3 Supports Hematopoietic Stem and Progenitor Cell Residence Within the Bone Marrow Niche.Engineering in vivo gradients of sphingosine-1-phosphate receptor ligands for localized microvascular remodeling and inflammatory cell positioningAcid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD.The promotion of mandibular defect healing by the targeting of S1P receptors and the recruitment of alternatively activated macrophages.Delivery of bioactive lipids from composite microgel-microsphere injectable scaffolds enhances stem cell recruitment and skeletal repair.Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesisSelective activation of sphingosine 1-phosphate receptors 1 and 3 promotes local microvascular network growthDiabetes-associated macrovascular complications: cell-based therapy a new tool?International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720.FTY720 promotes local microvascular network formation and regeneration of cranial bone defectsCirculating endothelial progenitor cells as a predictor of response to cardiac resynchronization therapy: the missing piece of the puzzle?Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization.cGMP-dependent protein kinase I is crucial for angiogenesis and postnatal vasculogenesisUnrestricted somatic stem cells from human umbilical cord blood grow in serum-free medium as spheres.PPARα regulates mobilization and homing of endothelial progenitor cells through the HIF-1α/SDF-1 pathway.S1P1 receptor directs the release of immature B cells from bone marrow into blood.Netrin-1 ameliorates myocardial infarction-induced myocardial injury: mechanisms of action in rats and diabetic mice.Targeting stem cell niches and trafficking for cardiovascular therapyRestoration of angiogenic capacity of diabetes-insulted mesenchymal stem cells by oxytocin.Discovery, design and synthesis of a selective S1P(3) receptor allosteric agonist.Lysophosphatidic acid enhances stromal cell-directed angiogenesis.Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system.The impact of bioactive lipids on cardiovascular development.Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β.Hypoxia augments outgrowth endothelial cell (OEC) sprouting and directed migration in response to sphingosine-1-phosphate (S1P).Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.FTY720 markedly increases alloengraftment but does not eliminate host anti-donor T cells that cause graft rejection on its withdrawal.Current perspectives on FTY720.The vascular S1P gradient-cellular sources and biological significance.Sphingosine kinase regulates the rate of endothelial progenitor cell differentiationAging and disease as modifiers of efficacy of cell therapy.
P2860
Q26750389-0B0B948A-0BF5-4F3F-BB79-A80BE9B71975Q26781269-F449B8E9-EBAB-491B-8F14-AD7E37720A8AQ26859168-70DE1D04-B97A-4525-99BF-04B6BF098922Q27003270-952A40AA-44B1-4BEF-9B3E-430A18212D5CQ27690654-737B59D7-472A-48F7-AAFA-A4C0153DF0C6Q27692619-20B387EF-0649-460C-83BF-8FF2BEEEBEC2Q28235893-CD1DEDF2-5D3E-4903-87BD-A44884585125Q28482255-8FC3D722-16D5-474C-8316-9EA11167BE1CQ30275148-271D7B2C-2F17-4373-819B-7798D1590591Q30370009-DCE23EC5-887A-4813-88B5-87147A82E9EAQ30370837-E488ACEB-0921-448C-8B94-40AE75471897Q30409209-00F9A702-0D82-4245-BDF6-CE4C58C9D879Q30411433-66ECBFB4-3A41-4F5C-AB2D-DA1D05EB3AE6Q30417313-30061D86-7812-4B6F-95D6-C7A3B118A62BQ30428199-A3221E4D-D75F-4226-B4EC-4FE3F20A8A4FQ30428895-2DE84069-5441-4156-8A41-9FAC29811E44Q30429523-452E2E4C-C67A-49C5-9113-AF1B8113D5A4Q30430805-3A47026A-47F0-4880-A286-375D86541B74Q30432193-762C2629-E19A-472E-9058-F9860B1D26CDQ33357429-2C3C0C81-36D4-4C58-9A35-16922F94FFD6Q33362774-45F984CF-C7AB-4B69-86FD-A5F66F199C29Q33418301-51687E74-0700-4D3A-B0BD-38170BF4ED61Q33518056-012961F0-C045-4283-A46F-FB127108D3D7Q33782638-18FBF9CE-44AF-4359-B914-D01036713030Q33839902-9C90AFFF-FB44-4BBE-B456-395E97FCE1C8Q34245510-74E79A92-4530-4CB6-B40C-967AA5A22764Q34475689-5B17A3BB-B0CA-47FD-BA69-C540BD72935DQ34984962-3CA41D70-B53E-4A3D-9F85-F2E4978E10E1Q35019936-D7B8AFB8-ABF0-466B-B5A8-943A8F73D694Q35061469-7CF8B4AD-4D9A-4D6E-966C-E6E27A1F8D2AQ35130512-F311BD90-C287-44A9-8D08-BD99CBAD5DF4Q35173287-52A6726D-83D4-4665-AEDE-6A313EE5B7CAQ35412507-02C3A039-3D81-49B9-BA37-99BD81925825Q35431408-642EF5A0-2B6B-4AAA-A535-24ED1B4B86A0Q35551835-716ECC27-5908-4507-BC06-03DEC014664BQ36462344-BFCEF8AA-BF45-4BD0-85A6-206FB6F48166Q36764024-75261D14-0EC0-453C-875C-D5908DF9ED33Q37085319-96733F03-DE72-49EE-8BC9-A58085783187Q37116962-CB99C398-5D23-416A-8861-0969EC1A016DQ37183949-0F89372C-D7D2-4873-8580-B78E187BD811
P2860
Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Sphingosine-1-phosphate stimul ...... pathway via the S1P3 receptor.
@ast
Sphingosine-1-phosphate stimul ...... pathway via the S1P3 receptor.
@en
type
label
Sphingosine-1-phosphate stimul ...... pathway via the S1P3 receptor.
@ast
Sphingosine-1-phosphate stimul ...... pathway via the S1P3 receptor.
@en
prefLabel
Sphingosine-1-phosphate stimul ...... pathway via the S1P3 receptor.
@ast
Sphingosine-1-phosphate stimul ...... pathway via the S1P3 receptor.
@en
P2093
P50
P1476
Sphingosine-1-phosphate stimul ...... pathway via the S1P3 receptor.
@en
P2093
Bodo Levkau
Dirk H Walter
Florian Seeger
Ioakim Spyridopoulos
Jerold Chun
Johannes Reinhold
Petra Keul
Ulrich Rochwalsky
Volker Brinkmann
P304
P356
10.1161/01.ATV.0000254669.12675.70
P407
P577
2006-12-07T00:00:00Z